tiprankstipranks
Tempest Therpeutics options imply 22.5% move in share price post-earnings
PremiumThe FlyTempest Therpeutics options imply 22.5% move in share price post-earnings
1M ago
Tempest Therapeutics, Inc. (TPST) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Tempest Therapeutics, Inc. (TPST) Q3 Earnings Cheat Sheet
2M ago
Morning Movers: GXO Logistics gains following report of potential sale
Premium
The Fly
Morning Movers: GXO Logistics gains following report of potential sale
2M ago
Tempest announces feedback form End-of-Phase 2 meeting with FDA for TPST-1120
PremiumThe FlyTempest announces feedback form End-of-Phase 2 meeting with FDA for TPST-1120
4M ago
TPST Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
TPST Upcoming Earnings Report: What to Expect?
4M ago
Tempest Therapeutics reports Q2 EPS (42c), consensus (40c)
Premium
The Fly
Tempest Therapeutics reports Q2 EPS (42c), consensus (40c)
5M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
9M ago
Tempest presents data showing PST-1120 reduces RCC growth as a monotherapy
Premium
The Fly
Tempest presents data showing PST-1120 reduces RCC growth as a monotherapy
9M ago
Tempest: Data from Phase 1 trial of TPST-1120 published in journal
Premium
The Fly
Tempest: Data from Phase 1 trial of TPST-1120 published in journal
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100